Omaha, NE 的 心臟衰竭 臨床試驗
13 項針對 心臟衰竭 的研究正在 Omaha（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
招募中3 期
- Be Well Clinical Studies, Omaha
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
招募中3 期
- University of Nebraska Medical Center, Omaha
Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
招募中
- University of Nebraska Medical Center, Omaha
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
招募中3 期
- Research Site, Omaha
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
招募中3 期
- CON-10018, Omaha, NE, Omaha
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
招募中3 期
- Omaha, NE Investigative Site 10018, Omaha
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
招募中
- University of Nebraska Medical Center, Omaha
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
招募中觀察性研究
- Omaha, Omaha
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
招募中觀察性研究
- CHI Health Reseach Center, Omaha
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
招募中3 期
- Tenax Investigational Site, Omaha
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
招募中
- University of Nebraska Medical Center, Omaha
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
招募中
- University of Nebraska Medical Center, Omaha
Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
招募中4 期
- Creighton University Medical Center, Omaha
其他城市的 心臟衰竭 試驗
- New York City, NY51 項研究
- Boston, MA44 項研究
- Dallas, TX42 項研究
- Houston, TX36 項研究
- Cleveland, OH33 項研究
- Chicago, IL31 項研究
- Philadelphia, PA31 項研究
- San Francisco, CA29 項研究
- St. Louis, MO26 項研究
- Durham, NC26 項研究
- Kansas City, MO25 項研究
- Atlanta, GA25 項研究
Omaha 的其他研究
- 前列腺癌27 項研究
- 非小細胞肺癌24 項研究
- 乳癌22 項研究
- 大腸直腸癌18 項研究
- 癌症（所有類型）18 項研究
- 多發性骨髓瘤16 項研究
- 非霍奇金淋巴瘤14 項研究
- 卵巢癌14 項研究
- 胰臟癌14 項研究
- 頭頸部鱗狀細胞癌13 項研究
- 轉移性癌症13 項研究
- 腎臟癌（腎細胞癌）12 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。